Additional file 1 of Higher-valency pneumococcal conjugate vaccines in older adults, taking into account indirect effects from childhood vaccination: a cost-effectiveness study for the Netherlands

Additional file 1: Supplementary introduction: Table S1. Summary of previous studies on the cost-effectiveness PCV15, PCV20 and PCV21 in adults. Supplementary Methods: Figure S1. Schematic overview of the model. Figure S2. The annual incidence of IPD cases in the Netherlands among adults aged ≥60 years per 100,000 inhabitants over the period 2004-2019 by serotype category. Figure S3. Fitted vaccine effectiveness of PPV23 against vaccine-type IPD and vaccine-type hospitalized NIPP at time of vaccination, across different vaccination ages. Figure S4. Fitted vaccine efficacy of PCVs against vacci... Mehr ...